Recent discussions about Mounjaro, a drug developed for weight loss management is gaining a lot of attention. One notable example is the BBC article, “Pharmacists in warning over weight-loss jab sales,” which highlights concerns raised by the National Pharmacy Association (NPA). In a letter to regulators, the NPA called for stricter guidelines on how the drug is prescribed, suggesting that a thorough, 20-minute consultation with a patient should be required rather than relying on online questionnaires to determine eligibility for medications like Mounjaro.
While Mounjaro has shown promising results for many individuals, it’s important to approach its use with caution. A safety-first mindset is crucial to ensure patients achieve lasting results without compromising their health. That’s why Streamline’s weight loss programme delivers an initial 30-minute video consultation with a weight loss expert (clinician) before prescribing any medication such as Mounjaro.
Mounjaro: promising results, but caution is key
Mounjaro is known as a dual action medication, targeting GIP (Glucose-dependent insulinotrophic polypeptide) receptors as well as GLP-1 receptors. This dual-action improves fat metabolism, further aiding weight loss beyond what standard GLP-1 medications can achieve. It’s been heralded as a breakthrough for those struggling with obesity, with many users experiencing substantial weight loss.
However, as with any new medication, there are reservations regarding its long-term safety and the risk of side effects, particularly when it is not used correctly or without ongoing clinical support. A number of online pharmacy providers are now offering weight loss medication via online questionnaires without the need to speak with a clinical expert or registered with the Care Quality Commission (CQC) who regulate healthcare services in the England.
While Mounjaro’s efficacy is promising, it’s crucial to remember that weight loss medications are not a one-size-fits-all solution. They should be prescribed as part of a programme and used alongside lifestyle changes, including proper diet and exercise, to yield lasting results. This is where a personalised, safety-first approach comes into play.
Why a safety-first approach is essential
Medication alone cannot address the underlying behaviours, eating habits, and emotional triggers that contribute to obesity and weight gain. Therefore, a comprehensive, clinically supervised programme is vital for a successful and safe weight loss journey.
At Streamline, we see patient safety as paramount in any decision to prescribe Mounjaro or any other weight loss medication, which is why a mandatory, video consultation is required prior to approval. This isn’t just a formality; it’s a crucial part of ensuring that each individual is suitable for medication, that any potential risk factors are addressed, and that the patient understands how to make lifestyle changes that will complement their treatment.
How does the consultation work?
The whole process of consulting prior to prescribing is designed to empower patients. During your consultation, patients are not only screened for suitability regarding Mounjaro but also receive tailored dietary guidance to support sustainable weight loss.
This consultation is primarily taken by one of our bariatric dietitian’s, whose expertise is essential because they help patients understand the complex relationship between food, metabolism, and overall health. This guidance ensures that individuals do not rely solely on medication but instead develop the skills to create lasting changes in their eating habits and lifestyle.
Moreover, our bariatric dietitians can identify any potential contraindications or complications that may arise from combining the medication with certain dietary habits or health conditions. They may also suggest more personalised interventions that align better with a patient’s specific needs.
A holistic approach to weight loss
Mounjaro and similar weight loss medications are most effective when used as part of a holistic approach that includes exercise and dietary adjustments. Weight loss is not simply about shedding pounds—it’s about creating a healthier, more sustainable lifestyle. By integrating the expertise of a dietitian, patients are better equipped to make informed decisions, avoid potential risks, and ensure that the medication complements their journey toward overall health improvement.
Streamline’s approach ensures that the use of Mounjaro or any other medication is not a shortcut or a quick fix, but part of a well-rounded plan that addresses the underlying factors contributing to weight gain. The 30-minute consultation is an opportunity to set the stage for long-term success, making sure that patients are empowered, informed, and safe as they move forward.
In conclusion
While Mounjaro offers an exciting avenue for weight loss management, it’s crucial to take a safety-first approach. A mandatory consultation with a bariatric dietitian before starting medication is an essential step in ensuring that individuals receive the guidance they need to make informed, healthy decisions. At Streamline, this proactive approach to care helps ensure that every patient is on the right track toward a healthier future—safely, sustainably, and with the right support every step of the way.
Streamline’s weight loss medication programme
Unlike other providers of weight loss medication, Streamline is owned and led by a team of weight loss surgeons with decades of experience in the field, bringing a unique perspective to weight loss treatment. Our deep understanding of weight management and metabolic health allows us to offer the best possible care and weight loss solutions, one of them being our weight loss medication programme.
What is included in our weight loss medication programme?
- Breakthrough weight loss medication
- Access to our health app, to track and monitor your progress
- 1:1 coaching and support from our team of experts
- Eco friendly, insulated packaging
If you’re interested in finding out more and to see if you’re eligible, please follow the link below:
